Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Acha-Orbea, H., Mitchell, D. J., Timmermann L., et al. (1988) Limited heterogeneity of T cell receptors from lymphocytes mediating autoimmune encephalomyelitis allows specific immune intervention. Cell 54:263–273.
Aharoni, R., Eilam R., Domev, H., et al. (2005) The immunomodulator glatiramer acetate augments the expression of neurotrophic factors in brains of experimental autoimmune encephalomyelitis mice. Proc. Natl. Acad. Sci. U S A 102:19045–19050.
Albert, M. L., Pearce, S. F., Francisco, L. M., et al. (1998) Immature dendritic cells phagocytose apoptotic cells via alphavbeta5 and CD36, and cross-present antigens to cytotoxic T lymphocytes. J. Exp. Med. 188:1359–1368.
Askenase, P. W., Hayden, B. J., Gershon, R. K. (1975) Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses. J. Exp. Med. 141:697–702.
Barrat, F. J., Cua, D. J., Boonstra, A., et al. (2002) In vitro generation of interleukin 10-producing regulatory CD4(+) T cells is induced by immunosuppressive drugs and inhibited by T helper type 1 (Th1)- and Th2-inducing cytokines. J. Exp. Med. 195:603–616.
Bielekova, B., Martin, R. (2001) Antigen-specific immunomodulation via altered peptide ligands. J. Mol. Med. 79:552–565.
Bielekova, B., Goodwin, B., Richert, N., et al. (2000) Encephalitogenic potential of the myelin basic protein peptide (amino acids 83–99) in multiple sclerosis: results of a phase II clinical trial with an altered peptide ligand. Nat. Med. 6:1167–1175.
Bienvenu, B., Martin, B., Auffray, C., et al. (2005) Peripheral CD8+CD25+ T lymphocytes from MHC class II-deficient mice exhibit regulatory activity. J. Immunol. 175:246–253.
Bisikirska, B., Colgan, J., Luban, J., et al. (2005) TCR stimulation with modified anti-CD3 mAb expands CD8+ T cell population and induces CD8+CD25+ Tregs. J. Clin. Invest. 115:2904–2913.
Bouneaud, C., Kourilsky, P., Bousso, P. (2000) Impact of negative selection on the T cell repertoire reactive to a self-peptide: a large fraction of T cell clones escapes clonal deletion. Immunity 13:829–840.
Brimnes, J., Allez, M., Dotan, I., et al. (2005) Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel disease. J. Immunol. 174:5814–5822.
Brocke, S., Gijbels, K., Allegretta, M., et al. (1996) Treatment of experimental encephalomyelitis with a peptide analogue of myelin basic protein. Nature 379:343–346.
Cantor, H., Shen, F. W., Boyse, E. A. (1976) Separation of helper T cells from suppressor T cells expressing different Ly components. II. Activation by antigen: after immunization, antigen-specific suppressor and helper activities are mediated by distinct T-cell subclasses. J. Exp. Med. 143:1391–1340.
Chang, C. C., Ciubotariu, R., Manavalan, J. S., et al. (2002) Tolerization of dendritic cells by T(S) cells: the crucial role of inhibitory receptors ILT3 and ILT4. Nat. Immunol. 3:237–243.
Chen, Z., Herman, A. E., Matos, M., et al. (2005) Where CD4+CD25+ T reg cells impinge on autoimmune diabetes. J. Exp. Med. 202:1387–1397.
Cosmi, L., Liotta, F., Lazzeri, E., et al. (2003) Human CD8+CD25+ thymocytes share phenotypic and functional features with CD4+CD25+ regulatory thymocytes. Blood. 102:4107–4114.
Cua, D. J., Hutchins, B., LaFace, D. M., et al. (2001) Central nervous system expression of IL-10 inhibits autoimmune encephalomyelitis. J. Immunol. 166:602–608.
Dhodapkar, M. V., Steinman, R. M. (2002) Antigen-bearing immature dendritic cells induce peptide-specific CD8(+) regulatory T cells in vivo in humans. Blood 100:174–177.
Ehrenstein, M. R., Evans, J. G., Singh, A., et al. (2004) Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFalpha therapy. J. Exp. Med. 200:277–285.
Faunce, D. E., Terajewicz, A., Stein-Streilein, J. (2004) Cutting edge: in vitro-generated tolerogenic APC induce CD8+ T regulatory cells that can suppress ongoing experimental autoimmune encephalomyelitis. J. Immunol. 172:1991–1995.
Feldmann, M., Steinman, L. (2005) Design of effective immunotherapy for human autoimmunity. Nature 435:612–619.
Filaci, G., Suciu-Foca, N. (2002) CD8+ T suppressor cells are back to the game: are they players in autoimmunity? Autoimmun. Rev. 1:279–283.
Fukaura, H., Kent, S. C., Pietrusewicz, M. J., et al. (1996) Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J. Clin. Invest. 98:70–77.
Gershon, R. K., Kondo, K. (1970) Cell interactions in the induction of tolerance: the role of thymic lymphocytes. Immunology 18:723–737.
Green, D. R., Webb, D. R. (1993) Saying the ‘S’ word in public. Immunol. Today 14:523–525.
Groux, H., O’Garra, A., Bigler, M., et al. 1997. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 389:737–742.
Hawiger, D., Inaba, K., Dorsett, Y., et al. (2001) Dendritic cells induce peripheral T cell unresponsiveness under steady state conditions in vivo. J. Exp. Med. 194:769–779.
Honda, A., Ametani, A., Matsumoto, T., et al. (2004) Vaccination with an immunodominant peptide of bovine type II collagen induces an anti-TCR response, and modulates the onset and severity of collagen-induced arthritis. Int. Immunol. 16:737–745.
Hong, J., Li, N., Zhang, X., et al. (2005) Induction of CD4+CD25+ regulatory T cells by copolymer-I through activation of transcription factor Foxp3. Proc. Natl. Acad. Sci. U S A 102:6449–6454.
Hori, S., Takahashi, T., Sakaguchi, S. (2003) Control of autoimmunity by naturally arising regulatory CD4+ T cells. Adv. Immunol. 81:331–371.
Howell, M. D., Winters, S. T., Olee, T., et al. (1989) Vaccination against experimental allergic encephalomyelitis with T cell receptor peptides. Science 246:668–670.
Jacobson, D. L., Gange, S. J., Rose, N. R., Graham, N. M. (1997) Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol 84:223–243.
Jiang, H., Chess, L. (2000) The specific regulation of immune responses by CD8+ T cells restricted by the MHC class Ib molecule, Qa-1. Annu. Rev. Immunol. 18:185–216.
Jiang, H., Zhang, S. I., Pernis, B. (1992) Role of CD8+ T cells in murine experimental allergic encephalomyelitis. Science 256:1213–1215.
Jiang, H., Ware, R., Stall, A., et al. (1995) Murine CD8+ T cells that specifically delete autologous CD4+ T cells expressing V beta 8 TCR: a role of the Qa-1 molecule. Immunity 2:185–194.
Jiang, H., Kashleva, H., Xu, L. X., et al. (1998) T cell vaccination induces T cell receptor Vbeta-specific Qa-1-restricted regulatory CD8(+) T cells. Proc. Natl. Acad. Sc.i U S A 95:4533–4537.
Jonuleit, H., Schmitt, E., Schuler, G., et al. (2000) Induction of interleukin 10-producing, nonproliferating CD4(+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:1213–1222.
Kabelitz, D., Pohl, T., Pechhold, K. (1993) Activation-induced cell death (apoptosis) of mature peripheral T lymphocytes. Immunol. Today 14:338–339.
Kappos, L., Comi, G., Panitch, H., et al. (2000) Induction of a non-encephalitogenic type 2 T helper-cell autoimmune response in multiple sclerosis after administration of an altered peptide ligand in a placebo-controlled, randomized phase II trial: the Altered Peptide Ligand in Relapsing MS Study Group. Nat. Med. 6:1176–1182.
Karandikar, N. J., Crawford, M. P., Yan, X., et al. (2002) Glatiramer acetate (Copaxone) therapy induces CD8(+) T cell responses in patients with multiple sclerosis. J. Clin. Invest. 109:641–649.
Keane, J., Gershon, S., Wise, R. P., et al. (2001) Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent. N. Engl. J. Med. 345:1098–1104.
Kelsen, J., Agnholt, J., Hoffmann, H. J., et al. (2005) FoxP3(+) CD4(+) CD25(+) T cells with regulatory properties can be cultured from colonic mucosa of patients with Crohn’s disease. Clin. Exp. Immunol. 141:549–557.
Kibler, R. F., Fritz, R. B., Chou, F., et al. (1977) Immune response of Lewis rats to peptide C1 (residues 68–88) of guinea pig and rat myelin basic proteins. J. Exp. Med. 146:1323–1331.
Koh, D. R., Fung-Leung, W. P., Ho, A., et al. (1992) Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice. Science 256:1210–1213.
Kohm, A. P., Carpentier, P. A., Anger, H. A., Miller, S. D. (2002) Cutting edge: CD4+CD25+ regulatory T cells suppress antigen-specific autoreactive immune responses and central nervous system inflammation during active experimental autoimmune encephalomyelitis. J. Immunol. 169:4712–4716.
Kumar, V. (2004) Homeostatic control of immunity by TCR peptide-specific Tregs. J. Clin. Invest. 114:1222–1226.
Kumar, V., Sercarz, E. E. (1993) The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease. J. Exp. Med. 178:909–916.
Kumar, V., Kono, D. H., Urban, J. L., Hood, L. (1989) The T-cell receptor repertoire and autoimmune diseases. Annu. Rev. Immunol. 7:657–682.
Kumar, V., Tabibiazar, R., Geysen, H. M., Sercarz, E. (1995) Immunodominant framework region 3 peptide from TCR V beta 8.2 chain controls murine experimental autoimmune encephalomyelitis. J. Immunol. 154:1941–1950.
Kumar, V., Coulsell, E., Ober, B., et al. (1997) Recombinant T cell receptor molecules can prevent and reverse experimental autoimmune encephalomyelitis: dose effects and involvement of both CD4 and CD8 T cells. J. Immunol. 159:5150–5156.
Kumar, V., Sercarz, E., Zhang, J., Cohen, I. (2001) T-cell vaccination: from basics to the clinic. Trends Immunol. 22:539–540.
Lan, R. Y., Ansari, A. A., Lian, Z. X., Gershwin, M. E. (2005) Regulatory T cells: development, function and role in autoimmunity. Autoimmun. Rev. 4:351–363.
Lindley, S. C., Dayan, M., Bishop, A., et al. (2005) Defective suppressor function in CD4(+) CD25(+) T-cells from patients with type 1 diabetes. Diabetes 54:92–99.
Madakamutil, L. T., Maricic, I., Sercarz, E., Kumar, V. (2003) Regulatory T cells control autoimmunity in vivo by inducing apoptotic depletion of activated pathogenic lymphocytes. J. Immunol. 170:2985–2992.
Manavalan, J. S., Kim-Schulze, S., Scotto, L., et al. (2004) Alloantigen specific CD8+CD28- FOXP3+ T suppressor cells induce ILT3+ ILT4+ tolerogenic endothelial cells, inhibiting alloreactivity. Int. Immunol. 16:1055–1068.
Martin, B., Banz, A., Bienvenu, B., et al. (2004) Suppression of CD4+ T lymphocyte effector functions by CD4+CD25+ cells in vivo. J. Immunol. 172:3391–3398.
Morgan, M. E., Flierman, R., van Duivenvoorde, L. M., et al. (2005) Effective treatment of collagen-induced arthritis by adoptive transfer of CD25+ regulatory T cells. Arthritis Rheum. 52:2212–2221.
Mougneau, E., Hugues, S., Glaichenhaus, N. (2002) Antigen presentation by dendritic cells in vivo. J. Exp. Med. 196:1013–1016.
Murali-Krishna, K., Altman, J. D., Suresh M., et al. (1998) Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8:177–187.
Nishizuka, Y., Sakakura, T. (1969) Thymus and reproduction: sex-linked dysgenesia of the gonad after neonatal thymectomy in mice. Science 166:753–755.
Panoutsakopoulou, V., Huster, K. M., McCarty, N., et al. (2004) Suppression of autoimmune disease after vaccination with autoreactive T cells that express Qa-1 peptide complexes. J. Clin. Invest. 113:1218–1224.
Pasare, C., Medzhitov, R. (2004) Toll-like receptors: linking innate and adaptive immunity. Microbes Infect. 6:1382–1387.
Piccirillo, C. A., Shevach, E. M. (2004) Naturally-occurring CD4+CD25+ immunoregulatory T cells: central players in the arena of peripheral tolerance. Semin. Immunol. 16:81–88.
Putnam, A. L., Vendrame, F., Dotta, F., Gottlieb, P. A. (2005) CD4+CD25 high regulatory T cells in human autoimmune diabetes. J. Autoimmun. 24:55–62.
Quattrocchi, E., Dallman, M. J., Dhillon, A. P., et al. (2001) Murine IL-10 gene transfer inhibits established collagen-induced arthritis and reduces adenovirus-mediated inflammatory responses in mouse liver. J. Immunol. 166:5970–5978.
Revel, M. (2003) Interferon-beta in the treatment of relapsing-remitting multiple sclerosis. Pharmacol. Ther. 100:49–62.
Sakaguchi, S. (2005) Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6:345–352.
Sakaguchi, S., Fukuma, K., Kuribayashi, K., Masuda, T. (1985) Organ-specific autoimmune diseases induced in mice by elimination of T cell subset. I. Evidence for the active participation of T cells in natural self-tolerance; deficit of a T cell subset as a possible cause of autoimmune disease. J. Exp. Med. 161:72–87.
Sakaguchi, S., Sakaguchi, N., Asano, M., et al. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25): breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol. 155:1151–1164.
Salgame, P., Abrams, J. S., Clayberger, C., et al. (1991) Differing lymphokine profiles of functional subsets of human CD4 and CD8 T cell clones. Science 254:279–282.
Sarantopoulos, S., Lu, L., Cantor, H. (2004) Qa-1 restriction of CD8+ suppressor T cells. J. Clin. Invest. 114:1218–1221.
Saruhan-Direskeneli, G., Weber, F., Meinl, E., et al. (1993) Human T cell autoimmunity against myelin basic protein: CD4+ cells recognizing epitopes of the T cell receptor beta chain from a myelin basic protein-specific T cell clone. Eur. J. Immunol. 23:530–536.
Schwartz, R. H. (2003) T cell anergy. Annu. Rev. Immunol. 21:305–334.
Sercarz, E. E., Lehmann, P. V., Ametani, A., et al. (1993) Dominance and crypticity of T cell antigenic determinants. Annu. Rev. Immunol. 11:729–766.
Shevach, E. M. (2000) Regulatory T cells in autoimmmunity. Annu. Rev. Immunol. 18:423–449.
Sun, D., Ben Nun, A., Wekerle, H. (1988) Regulatory circuits in autoimmunity: recruitment of counter-regulatory CD8+ T cells by encephalitogenic CD4+ T line cells. Eur. J. Immunol. 18:1993–1999.
Tang, X., Maricic, I., et al., Regulation of immunity by a novel population of Qa-1 restricted CD8 alpha +TCR alpha beta + T cells. J. Immunol. (in press).
Takatsu, K., Ishizaka, K. (1975) Reaginic antibody formation in the mouse. VI. Suppression of IgE and IgG antibody responses to ovalbumin following the administration of high dose urea-denatured antigen. Cell. Immunol. 20:276–289.
Thorstenson, K. M., Khoruts, A. (2001) Generation of anergic and potentially immunoregulatory CD25+CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol. 167:188–195.
Urban, J. L., Kumar, V., Kono, D. H., et al. (1988) Restricted use of T cell receptor V genes in murine autoimmune encephalomyelitis raises possibilities for antibody therapy. Cell 54:577–592.
Vandenbark, A. A., Hashim, G., Offner, H. (1989) Immunization with a synthetic T-cell receptor V-region peptide protects against experimental autoimmune encephalomyelitis. Nature 341:541–544.
Vandenbark, A. A., Chou, Y. K., Whitham, R., et al. (1996) Treatment of multiple sclerosis with T-cell receptor peptides: results of a double-blind pilot trial. Nat. Med. 2:1109–1115.
Viglietta, V., Baecher-Allan, C., Weiner, H. L., Hafler, D. A. (2004) Loss of functional suppression by CD4+CD25+ regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199:971–979.
Weiner, H. L. (2001) Induction and mechanism of action of transforming growth factor-beta-secreting Th3 regulatory cells. Immunol. Rev. 182:207–214.
Xystrakis, E., Dejean, A. S., Bernard, I., et al. (2004) Identification of a novel natural regulatory CD8 T-cell subset and analysis of its mechanism of regulation. Blood 104:3294–3301.
You, S., Chen, C., Lee, W. H., et al. (2004) Presence of diabetes-inhibiting, glutamic acid decarboxylase-specific, IL-10-dependent, regulatory T cells in naive nonobese diabetic mice. J. Immunol. 173:6777–6785.
Zamvil, S. S., Mitchell, D. J., Moore, A. C., et al. (1986) T-cell epitope of the autoantigen myelin basic protein that induces encephalomyelitis. Nature 324:258–260.
Zhang, J., Vandevyver, C., Stinissen, P., Raus J. (1995) In vivo clonotypic regulation of human myelin basic protein-reactive T cells by T cell vaccination. J. Immunol. 155:5868–5877.
Zhang, X., Izikson, L., Liu, L., Weiner, H. L. (2001) Activation of CD25(+) CD4(+) regulatory T cells by oral antigen administration. J. Immunol. 167:4245–4253.
Zimring, J. C., Kapp, J. A. (2004) Identification and characterization of CD8+ suppressor T cells. Immunol. Res. 29:303–312.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Smith, T.R.F., Tang, X., Kumar, V. (2007). Priming Regulatory T Cells and Antigen-Specific Suppression of Autoimmune Disease. In: Zhang, J. (eds) Immune Regulation and Immunotherapy in Autoimmune Disease. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-36003-4_2
Download citation
DOI: https://doi.org/10.1007/978-0-387-36003-4_2
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-36002-7
Online ISBN: 978-0-387-36003-4
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)